gsk

Welcome to the 'gsk' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'gsk'.

Are you an expert about 'gsk'? Do you want to be the Technorati authority on 'gsk'? You can write a description that will appear right here: Join Blogcritics!

Original Technorati articles tagged “gsk”

• in Business
  24/7 Wall St. Daily Market Roundup
  Technorati's new business feature, covering all you need to know to know what's going on in the markets.
  by 247WallSt / on Sep 23, 2010
• in Business
  24/7 Wall St. Morning Market Roundup
  Technorati's new business feature, covering all you need to know to know what's going on in the markets.
  by 247WallSt / on Jul 20, 2010
• in Business
  24/7 Wall St. Morning Market Roundup
  Technorati's new business feature, covering all you need to know to know what's going on in the markets.
  by 247WallSt / on Jul 14, 2010

Latest blogosphere posts tagged “gsk”

 

• IPO: Unproven Verastem

  
  TheStreet.com — Authority: 603
  Verastem is looking forpublic money even though this biotech company hasnt even tested its drugs on humans.
  2 days ago

• Excuse Me Waiter – There’s a Fly in My Vaccine Soup!

  
  Holy Hormones, Honey! — Authority: 120
  Please visit Holy Hormones Journal - The Greatest Story Never Told for similar articles. Vac Truth By Sandy Lunoe | January 21st, 2012 |   We can laugh at the waiter’s reply to our complaint about the fly in our soup:   “- Never mind, it won’t eat much!”  However it is no joke that vaccines ma ...
  6 days ago

• Seattle Genetics: Boxed Warning Is A Non-Event

  
  SeekingAlpha.com: Home Page — Authority: 548
  By ScriptVolume : Seattle Genetics ( SGEN ) announced a change in the labeling of Adcetris, warning patients on this treatment that they are at risk, albeit extremely small, to develop progressive multifocal leukoencephalopathy (PML) -a rare, but potentially fatal brain infection. The etiology of PML in patients on ...
  6 days ago

• Why Prolor Biotech Is Rising And Other Attractive Prospects

  
  SeekingAlpha.com: Home Page — Authority: 548
  By Takeover Analyst : PROLOR Biotech ( PBTH ) From positive clinical results to growing takeover potential, PROLOR has appreciated by nearly 50% for the year to date. As the pipeline marches forward, 2012 is gearing up to be an inflection point for the biotech firm. Based on attractive peer comparisons, ...
  1 week ago

• The Le Roy Twelve: Mass Hysteria? Gardasil? PANDAS? Aluminum Toxicity? – A Discussion on Environmental Factors, Mitochondrial Damage and Vaccine-Injury

  
  Holy Hormones, Honey! — Authority: 120
  Vax Truth Author: Marcella January 2012 Mitochondrial Damage Today’s latest on The Le Roy Twelve reveals there is finally a diagnosis for the mysterious tic disorders in these formerly healthy and vibrant young women:  “Mass Hysteria.”  The psychiatrists have determined that there is no real ...
  1 week ago

• Many Young HIV-Positive Women May Benefit From Cervical Cancer Vaccine

  
  Holy Hormones, Honey! — Authority: 120
  AIDSmeds January 17, 2012 Young women living with HIV may benefit from vaccinations that protect against cervical cancer, according to a new study showing that many HIV-positive women averaging 21 years of age are negative for the human papillomavirus (HPV) types typically associated with tumors, according to a new ...
  1 week ago

• Vivus’ ED Drug Continues to Hold Up – Analyst Blog

  
  Stock Market News & Stocks to Watch from StraightStocks — Authority: 150
  Positive data from a late-stage trial on Vivus Inc.s erectile dysfunction candidate, avanafil, was recently published in The Journal of Sexual Medicine.
  1 week ago

• Glaxo, Astex Call Off Agreement – Analyst Blog

  
  Stock Market News & Stocks to Watch from StraightStocks — Authority: 150
  GlaxoSmithKline and Astex announced that they are discontinuing a collaboration agreement
  1 week ago

• Investment Opportunities In 10 Big Pharmaceutical Companies

  
  SeekingAlpha.com: Home Page — Authority: 548
  By Marc Courtenay : "Theres nothing more powerful than an idea whose time has come", said Victor Hugo (1802-1885), recognized as the most influential French writer and poet of the 19th century. The man who brought us "Les Miserables" and "The Hunchback of Notre Dame" has been proven right on the above quote time ...
  1 week ago

• Buy, Sell, or Hold: Human Genome Sciences

  
  Fool.com: The Motley Fool — Authority: 696
  In a battle of risk versus reward, lets see which one comes out on top.
  1 week ago

• Questor Pharmaceuticals: Quickly Building A Multi-Billion Dollar Business

  
  SeekingAlpha.com: Home Page — Authority: 548
  By David White : Questor Pharmaceutical Inc. ( QCOR ) is a biopharmaceutical company that makes products for difficult to treat medical conditions. The companys efforts are currently focused on significant unmet needs in the fields of neurology and nephrology. The primary product is H.P. Acthar Gel (repository ...
  1 week ago

• Weekly Stock Watch: MNKD, DNDN, IMUC, CVM, CLDX, BDSI, GNBT, NBY, HGSI, BVTI, KERX

  
  The Market Playground — Authority: 463
  By VFC’s Stock House At the conclusion of each week, VFC’s Stock House examines the stocks and stories that made news through various sectors during previous trading week, but may also make headlines or influence trends during the upcoming week as well. This week the focus is on the biotechnology and ...
  1 week ago

• 4 Undervalued Dividend Stocks To Buy, 1 To Avoid

  
  SeekingAlpha.com: Home Page — Authority: 548
  By Investment Underground : Every portfolio must have pharmaceutical exposure to provide stability. It is easier said than done to identify great dividend-yielding stocks that enhance your portfolio through a solid, regular income stream. There are a wide variety of factors to consider, from the size of the company, ...
  1 week ago

• GlaxoSmithKline: Why Should It Be Avoided At These Prices

  
  SeekingAlpha.com: Home Page — Authority: 548
  By Alex Shadunsky : With GlaxoSmithKline ( GSK ) up more than 13% over the past year, outperforming the S&P by 13 percentage points, I decided to take a closer look into the company to see if it is still an attractive opportunity. Here are six points I looked at while researching GSK: Valuation: GSK’s ...
  1 week ago

• At least 12 schoolgirls in New York develop debilitating mystery illness, health department refuses to disclose cause (Gardasil?)

  
  Holy Hormones, Honey! — Authority: 120
  Natural News Friday, January 13, 2012 by: Ethan A. Huff, staff writer Twelve young schoolgirls from Le Roy Junior – Senior High School near Rochester, New York, recently became afflicted with a mysterious condition that caused them to develop tics and other symptoms similar to those associated with Tourette ...
  2 weeks ago

• Keeping An Eye On Isis

  
  SeekingAlpha.com: Home Page — Authority: 548
  By Jessica King Holden : Banking on drug discoveries can be a risky, frustrating financial investment. Science, like life (let alone the life science of biology) doesnt always follow a business plan. With the sector doing relatively well at the start of 2012, more attention may be shifting toward options here and ...
  2 weeks ago

• Fuld War Game 2011: Designer Foods — Abbott team defends its marketing plan

  
  Learn Free Internet Marketing Learn Free Internet Marketing Strategies using Video, Articles, Social Networking, Social Media, Web 2.0, Blogs, Affiliate Marketing — Authority: 142
  In this clip – The Abbott team, representing a company with a long history in the nutraceutical niche, presents its marketing plan to reach a broader consumer market but encounters resistance from the other teams and the judges. Opposing teams and judges all challenge Abbott on its ability to market purely consumer ...
  2 weeks ago

• Fast Money Recap: JPMorgans Tell

  
  TheStreet.com — Authority: 603
  NEW YORK (TheStreet) -- The markets ended up higher on Thursday on some encouraging reports on bond auctions in Spain and Italy. The Dow Jones Industrial Average rose 21.57, or 0.17%, to 12,471.02. The S&P; 500 added 3.02, or 0.23%, to 1295.50. And the Nasdaq was up 13.94, or 0.51%, to 2724.70. Guy Adami said ...
  2 weeks ago

• Fast Money Picks For January 13th (JPM, RBS, CHS, GSK, BBBY, CCL)

  
  Benzinga — Authority: 515
  On CNBCs Fast Money , Mike Khouw said that investors should consider buying short term calls in JPMorgan (NYSE:
  2 weeks ago

• Investing In Flu-Fighting Drug Makers

  
  SeekingAlpha.com: Home Page — Authority: 548
  James Holden submits: There are many strains of influenza virus, and new ones are constantly mutating. Strains of a virus tend to be organism-specific and can range in degree of infectiousness. Some, like H5N1, are found to infect mostly avian species (birds), while others, like H1N1, are more specific to swine. ...
  2 weeks ago

Comments about gsk